NASDAQ:GLMD
$0.651
(
-2.98%
)
Friday, 27th Jan 2023
Galmed Pharmaceuticals Ltd. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.405 | $0.95 | Friday, 27th Jan 2023 GLMD stock ended at $0.651. This is 2.98% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 10.63% from a day low at $0.650 to a day high of $0.719. |
| 90 days | $0.290 | $0.95 | |
| 52 weeks | $0.290 | $1.84 |
Historical Galmed Pharmaceuticals Ltd. prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $0.661 | $0.719 | $0.650 | $0.651 | 52 693 |
| 2023-01-26 | $0.656 | $0.690 | $0.635 | $0.671 | 64 609 |
| 2023-01-25 | $0.690 | $0.712 | $0.630 | $0.640 | 102 941 |
| 2023-01-24 | $0.700 | $0.757 | $0.690 | $0.707 | 68 899 |
| 2023-01-23 | $0.730 | $0.760 | $0.682 | $0.716 | 64 648 |
| 2023-01-20 | $0.741 | $0.772 | $0.700 | $0.751 | 85 625 |
| 2023-01-19 | $0.700 | $0.741 | $0.652 | $0.700 | 67 900 |
| 2023-01-18 | $0.700 | $0.781 | $0.650 | $0.700 | 207 534 |
| 2023-01-17 | $0.770 | $0.83 | $0.698 | $0.731 | 379 612 |
| 2023-01-13 | $0.82 | $0.86 | $0.716 | $0.80 | 233 927 |
| 2023-01-12 | $0.89 | $0.90 | $0.80 | $0.81 | 100 900 |
| 2023-01-11 | $0.94 | $0.94 | $0.87 | $0.88 | 37 954 |
| 2023-01-10 | $0.85 | $0.95 | $0.85 | $0.90 | 279 339 |
| 2023-01-09 | $0.799 | $0.85 | $0.790 | $0.83 | 227 139 |
| 2023-01-06 | $0.81 | $0.82 | $0.750 | $0.80 | 117 420 |
| 2023-01-05 | $0.742 | $0.84 | $0.732 | $0.80 | 144 456 |
| 2023-01-04 | $0.791 | $0.85 | $0.750 | $0.777 | 361 517 |
| 2023-01-03 | $0.673 | $0.720 | $0.520 | $0.711 | 436 442 |
| 2022-12-30 | $0.460 | $0.524 | $0.450 | $0.500 | 60 723 |
| 2022-12-29 | $0.405 | $0.530 | $0.405 | $0.460 | 329 902 |
| 2022-12-28 | $0.500 | $0.540 | $0.472 | $0.472 | 221 989 |
| 2022-12-27 | $0.587 | $0.587 | $0.479 | $0.540 | 169 705 |
| 2022-12-23 | $0.590 | $0.630 | $0.502 | $0.538 | 253 274 |
| 2022-12-22 | $0.450 | $0.640 | $0.450 | $0.590 | 640 558 |
| 2022-12-21 | $0.304 | $0.550 | $0.301 | $0.451 | 1 510 147 |
| 2022-12-20 | $0.290 | $0.320 | $0.290 | $0.310 | 207 378 |
| 2022-12-19 | $0.300 | $0.362 | $0.296 | $0.340 | 727 636 |
| 2022-12-16 | $0.300 | $0.300 | $0.290 | $0.290 | 109 550 |
| 2022-12-15 | $0.300 | $0.300 | $0.290 | $0.290 | 36 910 |
| 2022-12-14 | $0.290 | $0.300 | $0.290 | $0.300 | 50 021 |
| 2022-12-13 | $0.301 | $0.310 | $0.290 | $0.299 | 80 416 |
| 2022-12-12 | $0.307 | $0.319 | $0.290 | $0.310 | 200 168 |
| 2022-12-09 | $0.300 | $0.317 | $0.290 | $0.290 | 63 138 |
| 2022-12-08 | $0.290 | $0.311 | $0.290 | $0.290 | 27 302 |
| 2022-12-07 | $0.305 | $0.305 | $0.290 | $0.295 | 46 057 |
| 2022-12-06 | $0.305 | $0.305 | $0.291 | $0.294 | 35 678 |
| 2022-12-05 | $0.290 | $0.319 | $0.290 | $0.317 | 15 025 |
| 2022-12-02 | $0.300 | $0.319 | $0.300 | $0.306 | 7 483 |
| 2022-12-01 | $0.300 | $0.306 | $0.291 | $0.300 | 44 827 |
| 2022-11-30 | $0.293 | $0.308 | $0.290 | $0.292 | 20 166 |
| 2022-11-29 | $0.298 | $0.319 | $0.290 | $0.298 | 40 870 |
| 2022-11-28 | $0.300 | $0.329 | $0.298 | $0.320 | 15 273 |
| 2022-11-25 | $0.310 | $0.330 | $0.300 | $0.300 | 28 443 |
| 2022-11-23 | $0.320 | $0.337 | $0.300 | $0.301 | 33 231 |
| 2022-11-22 | $0.330 | $0.340 | $0.320 | $0.321 | 18 741 |
| 2022-11-21 | $0.322 | $0.340 | $0.320 | $0.320 | 24 082 |
| 2022-11-18 | $0.328 | $0.340 | $0.320 | $0.327 | 3 431 |
| 2022-11-17 | $0.330 | $0.340 | $0.321 | $0.330 | 24 403 |
| 2022-11-16 | $0.340 | $0.340 | $0.321 | $0.336 | 8 060 |
| 2022-11-15 | $0.314 | $0.340 | $0.314 | $0.330 | 45 827 |
About Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
